04/05/2026 22:11
|
Medical, Health & Aged Care
* Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patients
OSAKA, Japan & CAMBRIDGE, Mass.--BUSINESS...